6-Desacetyl Palbociclib
An impurity of Palbociclib, a selective inhibitor of cyclin-dependent kinases CDK4 and CDK6. Palbociclib is developed for the treatment of ER-positive and HER2-negative breast cancer.
| Supplier | BOC Sciences |
|---|---|
| Product # | B1476-478511 |
| Pricing | 100 mg/unit USD $1454 |
| Cas | 571190-22-2 |
| Molecular Weight | 405.506 |
| Molecular Formula | C22H27N7O |
| Canonical SMILES | CC1=CC(=O)N(C2=NC(=NC=C12)NC3=NC=C(C=C3)N4CCNCC4)C5CCCC5 |